Institutional Ownership
Ocean Biomedical Inc
CUSIP 67644C104COMOCEAQ1 2026
13D / 13G Filings
10
Schedule 13D/13G on record
Beneficial Filers
8
Distinct reporting persons
Largest Stake
62.5%
Max % of class reported
Institutional Holders
1
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
10 filings · latest Feb 13, 2025
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Feb 13, 2025 | Ayrton Capital LLC | 13G/A | 9.9% | 3.87M | SEC |
| 2 | Feb 14, 2024 | Ayrton Capital LLC | 13G | 9.9% | 3.78M | SEC |
| 3 | Feb 13, 2024 | Atw Spac Management LLC | 13G/A | — | — | SEC |
| 4 | Feb 13, 2024 | Boothbay Fund Management, LLC | 13G/A | — | — | SEC |
| 5 | Feb 9, 2024 | Polar Asset Management Partners Inc. | 13G/A | 7.7% | 2.69M | SEC |
| 6 | Jan 26, 2024 | Weiss Asset Management LP | 13G/A | — | — | SEC |
| 7 | Mar 24, 2023 | Aesther Healthcare Sponsor, LLC | 13D/A | 6.7% | 2.36M | SEC |
| 8 | Feb 24, 2023 | Aesther Healthcare Sponsor, LLC | 13D | 19.9% | 8.35M | SEC |
| 9 | Feb 24, 2023 | Poseidon Bio, LLC | 13D | 62.5% | 22.84M | SEC |
| 10 | Feb 17, 2023 | Vellar Opportunities Fund Master, Ltd. | 13G/A | 4.3% | 1.52M | SEC |
Top Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Fny Investment Advisers, LLC | 600 | $0 |